Cite
HARVARD Citation
Baraliakos, X. et al. (2013). FRI0420 Long term inhibition of IL-17a with secukinumab reduces spinal inflammation but has no influence on fatty lesions as assessed by magnetic resonance imaging in patients with ankylosing spondylitis. Annals of the rheumatic diseases. p. A516. [Online].